Ciltoprazine is a 5-chloro-2-methoxy-benzamide derivative that has been studied as muscule relaxant

Englitazone is a thiazolidinedione antidiabetic agent. It has insulinomimetic and insulin-enhancing actions in vitro and glucose-, insulin-, triglyceride-, and cholesterol-lowering properties in an animal model of non-insulin-dependent diabetes mellitus. It acts as a peroxisome-proliferator-activated receptor-gamma ligand. Englitazone inhibits ATP-sensitive potassium and calcium-activated non-selective cation channels in a voltage-independent manner.

Enprazepine is an antidepressant.

Butamoxane is aminomethyl-benzodioxane derivative with sympatholytic activity. Butamoxane showes a central action as well as the adrenaline-antagonizing action.

Butanserin is the potent and selective alpha 1-adrenoceptor antagonist.

Mitoclomine, an alkylating agent was developed to treat cancer. This drug was involved in phase I/II clinical trial to treat patients with chronic lymphocytic leukemia. Information about the further development of a drug is not available.

Moctamide is a synthetic linoleamide derivative patented by major Japanese chemical company Sumitomo Chemical Co., Ltd. as hypocholesterolemic agent useful as prophylactics against arteriosclerosis. Administration of Moctamide significantly lowered serum and liver cholesterol and significantly prevented formation of aortic atheromatous changes in animal models.

FLUINDAROL, an indanedione derivative, is an anticoagulant.